Apotex Inc. v. Sanofi-Aventis, 2013 FCA 187 (Clopidogrel*)
Justice Pelletier; Justice Gauthier; Justice Noël - 2013-07-24
Read full decision. Automatically generated summary:
This is an appeal from the order of costs made following a 26 day trial in which the Federal Court found that Canadian Patent No. 1,336,777 (the '777 Patent) was invalid for lack of utility and obviousness. The appellants argue that the Federal Court erred in denying them certain of their disbursements. In File No. A-7-12, this Court overturned the Federal Court's decision, upheld the validity of the '777 Patent, and ordered costs against the appellant Apotex in this Court and in the Federal Court. As a result, this appeal is now moot.
Decision relates to:
- A-121-12 - APOTEX INC ET AL v. SANOFI -AVENTIS ET AL which is an appeal from 2012 FC 318 in T-644-09